Studies of nuclear receptor corepressor, NRIP1, in vitamin A signaling pathways
Studies of nuclear receptor corepressor, NRIP1, in vitamin A signaling pathways
批准号:
7452085
负责人:
Li-Na Wei
金额:
$31.59万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-03-15 至 2013-03-31
关键词:
AddressAdipocytesAffectAnimal ModelArginineBiologicalBiological ProcessCell Differentiation processCellsChromatinChromatin Remodeling FactorClinicalComplexDefectDiseaseEP300 geneEmbryoEmbryonal CarcinomaEndocrineEventFibroblastsFigs - dietaryGene ConversionGene ExpressionGene TargetingGenesGenetic TranscriptionGoalsHealthHistone DeacetylaseHistonesHomeostasisHormonalHormone ReceptorHormonesHumanKineticsKnock-outKnowledgeLeftLigandsMaintenanceMediatingMediator of activation proteinMetabolic DiseasesMethylationModelingModificationModification TypeMolecularMolecular Mechanisms of ActionMusMutateNRIP1 geneNuclear ReceptorsNucleic Acid Regulatory SequencesNucleosomesNutrientNutritionalPCAF genePPARBP genePhasePlayPost-Translational Protein ProcessingProgress ReportsPropertyPublic HealthRNA Polymerase IIRXRRecruitment ActivityRegulationRepressionRetinoic Acid BindingRetinoic Acid ReceptorRoleSignal PathwaySignal TransductionSmall Interfering RNASupplementationSystemTestingThyroid HormonesTransferaseTretinoinVitamin Aadipocyte differentiationcell typecellular retinoic acid binding protein Ichromatin remodelinggenetically modified cellshormone response elementhuman NRIP1 proteininsightmouse modelmutantnovelprogramsreceptortranscription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Retinoic acid (RA), the biologically active form of Vitamin A, is essential for a variety of biological processes. RA binds to nuclear receptors, retinoic acid receptor (RAR) and retinoid receptor X (RXR), to regulate target gene expression by triggering recruitment of coregulators that act, primarily, through chromatin remodeling and modification on the regulatory regions of target genes. Nuclear Receptor Interacting Protein 1 (NRIP1, originally known as RIP140) is a ligand-dependent co-repressor, i.e. it represses hormonal induction of target gene expression in a hormone-dependent manner. The long-term goal of this project is to understand the mechanisms underlying homeostatic control of vitamin A signaling. The proposal focuses on chromatin remodeling events orchestrated by RIP140 and coactivators that form complexes with hormone receptors, such as RIP140-RAR/RXR complex and coactivator-RAR/RXR complexes, as well as the biological significance of several newly identified post-translational modifications in the modulation of receptor/coregulator activities. Two questions will be addressed: 1) how does RIP140 function in hormone-induced chromatin remodeling? 2) How does protein modification regulate the biological activity of RIP140? Wild type and genetically modified cells, including RIP140-knockout (RIP-/-) and TRAP220-knockout (TRAP-/-) cells, as well siRNA mediated gene knockdown in P19 cells will be used as the principal experimental systems. Chromatin segments containing hormone response elements (HREs) will be the targets of examination to address mechanistic details in a physiologically relevant context. These studies will provide mechanistic insights into crosstalk of hormones (vitamin A and thyroid hormones) via coordinated formation of specific transcription factor complexes. These studies will also uncover potentially novel signals and cellular factors that are critical to cell differentiation program where vitamin A and other endocrine factors play vital roles. Knowledge gained from these studies could also be applied to understand clinical diseases that are affected by, or involve, hormonal and nutritional factors, such as metabolic diseases, the studies will also delineate the role of nutrients, such as vitamin A, in the maintenance of human health. PUBLIC HEALTH RELEVANCE: Retinoic acid (RA), the biologically active form of Vitamin A, is essential for a variety of biological processes. RA functions by regulating target gene expression through chromatin remodeling that involves Nuclear Receptor Interacting Protein 1 (NRIP1, originally known as RIP140). The long-term goal of this project is to understand the mechanisms underlying homeostatic control of vitamin A signaling. The current proposal focuses on the functional role of NRIP1 from a mechanistic stand point. Knowledge gained from these studies could also be applied to understand clinical diseases that are affected by, or involve, hormonal and nutritional factors, such as metabolic diseases. The studies will also delineate the role of nutrients, such as vitamin A, in the maintenance of human health.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
FASEB SRC on
-
批准号:8719401
-
项目类别:
-
资助金额:$4.0万
-
财政年份:2014
-
负责人:Li-Na Wei
-
依托单位:
Studies of nuclear receptor corepressor, NRIP1, in vitamin A signaling pathways
-
批准号:8007006
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2010
-
负责人:Li-Na Wei
-
依托单位:
TR2 nuclear receptor in vitamin A signaling
-
批准号:8010070
-
项目类别:
-
资助金额:$13.25万
-
财政年份:2010
-
负责人:Li-Na Wei
-
依托单位:
Molecular Mechanisms of Ontogenesis of K-Opioid Receptors
-
批准号:7612853
-
项目类别:
-
资助金额:$7.35万
-
财政年份:2008
-
负责人:Li-Na Wei
-
依托单位:
Studies of the Mouse Kappa Opioid Receptor Gene
-
批准号:7599011
-
项目类别:
-
资助金额:$12.87万
-
财政年份:2007
-
负责人:Li-Na Wei
-
依托单位:
Studies of the Mouse Kappa Opioid Receptor Gene
-
批准号:7802336
-
项目类别:
-
资助金额:$12.87万
-
财政年份:2007
-
负责人:Li-Na Wei
-
依托单位:
Mechanisms of Ontogenesis of Kappa Opioid Receptors
-
批准号:7513843
-
项目类别:
-
资助金额:$11.36万
-
财政年份:2007
-
负责人:Li-Na Wei
-
依托单位:
Studies of the Mouse Kappa Opioid Receptor Gene
-
批准号:7190873
-
项目类别:
-
资助金额:$12.87万
-
财政年份:2007
-
负责人:Li-Na Wei
-
依托单位:
Studies of the Mouse Kappa Opioid Receptor Gene
-
批准号:7409730
-
项目类别:
-
资助金额:$12.87万
-
财政年份:2007
-
负责人:Li-Na Wei
-
依托单位:
Studies of the Mouse Kappa Opioid Receptor Gene
-
批准号:8040951
-
项目类别:
-
资助金额:$12.87万
-
财政年份:2007
-
负责人:Li-Na Wei
-
依托单位:
NRIP1 in vitamin A signaling pathways
-
批准号:6620340
-
项目类别:
-
资助金额:$25.29万
-
财政年份:2002
-
负责人:Li-Na Wei
-
依托单位:
Studies of the mouse kappa opioid receptor gene
-
批准号:6864823
-
项目类别:
-
资助金额:$12.36万
-
财政年份:2002
-
负责人:Li-Na Wei
-
依托单位:
Studies of nuclear receptor corepressor, NRIP1, in vitamin A signaling pathways
-
批准号:8913322
-
项目类别:
-
资助金额:$8.51万
-
财政年份:2002
-
负责人:Li-Na Wei
-
依托单位:
Studies of nuclear receptor corepressor, NRIP1, in vitamin A signaling pathways
-
批准号:7591104
-
项目类别:
-
资助金额:$31.57万
-
财政年份:2002
-
负责人:Li-Na Wei
-
依托单位:
Studies of nuclear receptor corepressor, NRIP1, in vitamin A signaling pathways
-
批准号:7787456
-
项目类别:
-
资助金额:$31.24万
-
财政年份:2002
-
负责人:Li-Na Wei
-
依托单位:
NRIP1 in vitamin A signaling pathways
-
批准号:6415785
-
项目类别:
-
资助金额:$28.77万
-
财政年份:2002
-
负责人:Li-Na Wei
-
依托单位:
NRIP1 in vitamin A signaling pathways
-
批准号:6874306
-
项目类别:
-
资助金额:$25.29万
-
财政年份:2002
-
负责人:Li-Na Wei
-
依托单位:
Studies of the mouse kappa opioid receptor gene
-
批准号:6621101
-
项目类别:
-
资助金额:$10.31万
-
财政年份:2002
-
负责人:Li-Na Wei
-
依托单位:
Studies of nuclear receptor corepressor, NRIP1, in vitamin A signaling pathways
-
批准号:8867875
-
项目类别:
-
资助金额:$40.88万
-
财政年份:2002
-
负责人:Li-Na Wei
-
依托单位:
Studies of nuclear receptor corepressor, NRIP1, in vitamin A signaling pathways
-
批准号:9892993
-
项目类别:
-
资助金额:$42.26万
-
财政年份:2002
-
负责人:Li-Na Wei
-
依托单位:
国内基金
海外基金
支链氨基酸代谢紊乱调控“Adipocytes - Macrophages Crosstalk”诱发2型糖尿病脂肪组织功能和结构障碍的作用及机制
-
批准号:81970721
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:陶凌
-
依托单位: